Overview

Cognition in the Study of Tamoxifen and Raloxifene

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.
Phase:
Phase 3
Details
Lead Sponsor:
Wake Forest University
Collaborator:
National Institute on Aging (NIA)
Treatments:
Estrogen Receptor Modulators
Raloxifene Hydrochloride
Selective Estrogen Receptor Modulators
Tamoxifen